Physician
Massena Hospital INC
Massena Hospital INC was paid $18.16M by Medicaid between Jan 2018 and Dec 2024, across 246 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 15% of everything it billed.
33Billing provider infoMASSENA HOSPITAL INC
MASSENA, NY 13662
MASSENA, NY 13662
33aNPI1972604460assigned 09/26/2006
33bProvider typeAnesthesiology Physician
28Total paid$18.16M
24GClaims365,912
24DCodes billed246
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Anesthesiology Physician providers in New York
Rank by total paid#2 of 493
Median peer was paid$8K
This provider vs. median2,359×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,076 | $316K | |
| 2019 | 33,704 | $1.32M | |
| 2020 | 63,612 | $2.35M | |
| 2021 | 79,469 | $3.25M | |
| 2022 | 75,477 | $5.41M | |
| 2023 | 64,201 | $3.72M | |
| 2024incomplete | 41,373 | $1.79M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 15% | 27,693 | 25,872 | $2.81M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15% | 31,545 | 28,900 | $2.71M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 12% | 17,501 | 16,608 | $2.15M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 9.3% | 15,538 | 14,676 | $1.70M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.9% | 7,272 | 6,915 | $897K |
| 96361 | Intravenous infusion, hydration; each additional hour | 3.5% | 2,154 | 1,829 | $638K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.4% | 2,598 | 2,551 | $432K |
| 80053 | Comprehensive metabolic panel | 2.3% | 19,038 | 17,226 | $415K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.1% | 1,513 | 1,483 | $385K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.1% | 4,471 | 1,482 | $384K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.0% | 8,505 | 7,848 | $365K |
| 36415 | Collection of venous blood by venipuncture | 1.9% | 20,292 | 15,830 | $344K |
234 more codes
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.7% | 1,092 | $304K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.7% | 1,122 | $301K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.5% | 1,850 | $280K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.5% | 4,226 | $266K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.1% | 2,188 | $193K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 1,869 | $174K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,463 | $171K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 2,074 | $170K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 590 | $142K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 2,446 | $127K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 3,920 | $124K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 1,259 | $120K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,622 | $117K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 2,539 | $115K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,878 | $99K |
| 87486 | <1% | 842 | $98K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 751 | $95K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 632 | $94K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 520 | $87K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 287 | $77K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 544 | $72K |
| 97161 | <1% | 527 | $65K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,168 | $63K |
| 81025 | <1% | 1,271 | $50K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 834 | $49K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 6,916 | $46K |
| 80061 | Lipid panel | <1% | 6,130 | $43K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 1,248 | $42K |
| 87631 | <1% | 521 | $40K | |
| 97010 | <1% | 1,727 | $38K | |
| 86850 | <1% | 953 | $38K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 289 | $38K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 4,514 | $37K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,875 | $36K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 686 | $35K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 19,532 | $33K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,232 | $33K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 1,467 | $32K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 620 | $30K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 163 | $30K |
| 97162 | <1% | 147 | $30K | |
| 76830 | Ultrasound, transvaginal | <1% | 613 | $29K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 283 | $28K |
| 90686 | <1% | 1,070 | $28K | |
| G0378 | Hospital observation service, per hour | <1% | 134 | $26K |
| 97035 | <1% | 405 | $26K | |
| 99173 | <1% | 688 | $23K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 419 | $22K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,153 | $21K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 2,626 | $21K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 2,884 | $21K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 527 | $21K |
| 84439 | <1% | 3,065 | $20K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 1,818 | $19K |
| 95886 | <1% | 289 | $19K | |
| 86901 | <1% | 1,010 | $18K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 830 | $17K |
| 90715 | <1% | 595 | $17K | |
| 87581 | <1% | 842 | $16K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 58 | $16K |
| 82728 | <1% | 1,435 | $16K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 53 | $16K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 152 | $15K |
| 86900 | <1% | 1,007 | $15K | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 540 | $15K |
| 90670 | <1% | 676 | $14K | |
| 83655 | <1% | 992 | $13K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 584 | $13K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 296 | $12K |
| 82607 | <1% | 1,148 | $12K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 349 | $12K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 170 | $10K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,596 | $10K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 77 | $10K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 766 | $10K |
| 82803 | <1% | 331 | $9K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 82 | $9K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,201 | $9K |
| 84702 | <1% | 1,882 | $9K | |
| 36000 | <1% | 2,114 | $9K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 650 | $9K |
| 83880 | <1% | 337 | $9K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 179 | $8K |
| 97014 | <1% | 667 | $8K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 24 | $8K |
| 82805 | <1% | 300 | $7K | |
| 96367 | <1% | 138 | $7K | |
| 86803 | <1% | 1,006 | $7K | |
| 88142 | <1% | 287 | $7K | |
| 90734 | <1% | 297 | $7K | |
| 85610 | <1% | 2,579 | $7K | |
| 83735 | <1% | 2,503 | $7K | |
| 71250 | <1% | 52 | $6K | |
| 83540 | <1% | 1,530 | $6K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,999 | $6K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 4,372 | $6K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,212 | $5K |
| 82570 | <1% | 1,214 | $5K | |
| 83550 | <1% | 1,289 | $5K | |
| 29125 | <1% | 28 | $5K | |
| 82746 | <1% | 483 | $5K | |
| 99205 | Prolong outpt/office vis | <1% | 19 | $5K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 55 | $4K |
| 99441 | <1% | 176 | $4K | |
| 99442 | <1% | 74 | $4K | |
| 82043 | <1% | 1,058 | $4K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 143 | $4K |
| 87340 | <1% | 585 | $4K | |
| 90648 | <1% | 311 | $4K | |
| 81001 | <1% | 4,656 | $4K | |
| 90837 | Psychotherapy session, about an hour | <1% | 15 | $4K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 46 | $3K |
| 86140 | <1% | 1,398 | $3K | |
| 90651 | <1% | 99 | $3K | |
| 87186 | <1% | 1,241 | $3K | |
| 86780 | <1% | 318 | $2K | |
| 81003 | <1% | 3,213 | $2K | |
| 90633 | <1% | 221 | $2K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 107 | $2K |
| 73630 | <1% | 558 | $2K | |
| 85027 | <1% | 944 | $2K | |
| 87077 | <1% | 795 | $2K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 42 | $2K |
| 90688 | <1% | 66 | $2K | |
| 99443 | <1% | 26 | $2K | |
| 90716 | <1% | 31 | $2K | |
| 87070 | <1% | 428 | $2K | |
| 76641 | <1% | 29 | $2K | |
| 84153 | <1% | 85 | $1K | |
| 80305 | <1% | 1,333 | $1K | |
| 83690 | <1% | 3,680 | $1K | |
| 84436 | <1% | 269 | $1K | |
| 85730 | <1% | 1,043 | $1K | |
| 95912 | <1% | 24 | $1K | |
| 86618 | <1% | 134 | $1K | |
| 59025 | Fetal non-stress test | <1% | 40 | $1K |
| 85652 | <1% | 1,136 | $1K | |
| 87210 | <1% | 884 | $1K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,022 | $1K |
| 76801 | <1% | 12 | $1K | |
| 71045 | Radiologic examination, chest; single view | <1% | 2,364 | $879.01 |
| 90681 | <1% | 63 | $821.09 | |
| 90685 | <1% | 56 | $774.23 | |
| 90723 | <1% | 197 | $770.41 | |
| 87468 | <1% | 24 | $690.59 | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 26 | $678.07 |
| 84484 | <1% | 3,376 | $673.22 | |
| 71271 | <1% | 37 | $633.30 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 3,061 | $622.50 |
| 86592 | <1% | 264 | $614.57 | |
| 73610 | <1% | 343 | $599.06 | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 13 | $592.71 |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 26 | $564.02 |
| 90707 | <1% | 34 | $559.31 | |
| 86762 | <1% | 40 | $530.26 | |
| 85379 | <1% | 830 | $529.47 | |
| 73030 | <1% | 116 | $516.15 | |
| 87469 | <1% | 24 | $477.96 | |
| 87478 | <1% | 24 | $477.96 | |
| 87484 | <1% | 24 | $477.96 | |
| 94760 | <1% | 139 | $464.49 | |
| 84100 | <1% | 166 | $450.25 | |
| 82550 | <1% | 869 | $446.02 | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 14 | $435.97 |
| 74018 | <1% | 164 | $429.02 | |
| 87807 | <1% | 153 | $424.96 | |
| 83605 | <1% | 1,607 | $410.78 | |
| 80306 | <1% | 523 | $376.86 | |
| 87040 | <1% | 934 | $359.57 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,529 | $352.57 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 81 | $348.00 |
| 84703 | <1% | 1,955 | $332.15 | |
| 80335 | <1% | 159 | $324.50 | |
| 86706 | <1% | 56 | $318.05 | |
| 82248 | <1% | 130 | $308.84 | |
| 90656 | <1% | 14 | $276.82 | |
| 82150 | <1% | 291 | $241.83 | |
| 73564 | <1% | 55 | $238.12 | |
| 82784 | <1% | 13 | $223.20 | |
| G0008 | Administration of influenza virus vaccine | <1% | 22 | $200.40 |
| 76536 | <1% | 13 | $199.62 | |
| 90710 | <1% | 136 | $178.50 | |
| 87400 | <1% | 144 | $172.98 | |
| 73130 | <1% | 118 | $172.66 | |
| 80320 | <1% | 321 | $172.18 | |
| 86709 | <1% | 59 | $157.70 | |
| 72110 | <1% | 12 | $156.00 | |
| 82553 | <1% | 376 | $147.60 | |
| 84550 | <1% | 38 | $142.94 | |
| 90461 | <1% | 410 | $132.29 | |
| 86038 | <1% | 26 | $128.27 | |
| 80076 | <1% | 17 | $107.56 | |
| 86708 | <1% | 30 | $101.92 | |
| 81002 | <1% | 326 | $82.02 | |
| 82950 | <1% | 14 | $79.66 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,300 | $79.61 |
| 86787 | <1% | 12 | $75.57 | |
| 87081 | <1% | 293 | $72.80 | |
| 84156 | <1% | 30 | $67.49 | |
| 82565 | <1% | 15 | $65.39 | |
| 86431 | <1% | 12 | $62.95 | |
| 82948 | <1% | 85 | $60.03 | |
| 73110 | <1% | 55 | $60.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 566 | $56.25 |
| 90647 | <1% | 28 | $53.55 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 601 | $45.91 |
| 84479 | <1% | 14 | $39.87 | |
| 93041 | <1% | 922 | $34.74 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 83 | $29.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,972 | $19.47 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 266 | $19.35 |
| 86308 | <1% | 12 | $18.92 | |
| 90696 | <1% | 13 | $17.85 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 879 | $9.16 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 347 | $6.84 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 117 | $6.80 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 281 | $4.46 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 76 | $3.06 |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | <1% | 124 | $0.77 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 86 | $0.05 |
| 80143 | 0% | 27 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 1,007 | $0.00 |
| J0136 | Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg | 0% | 94 | $0.00 |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | 0% | 66 | $0.00 |
| 73562 | 0% | 14 | $0.00 | |
| J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg | 0% | 81 | $0.00 |
| 80179 | 0% | 14 | $0.00 | |
| 96376 | 0% | 186 | $0.00 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 205 | $0.00 |
| 96127 | 0% | 137 | $0.00 | |
| J2704 | Injection, propofol, 10 mg | 0% | 71 | $0.00 |
| 80329 | 0% | 58 | $0.00 | |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 17 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBENDER, DAVID (CEO/AO)